Collegium Pharmaceutical (COLL) Inventory Average (2016 - 2026)

Collegium Pharmaceutical's Inventory Average history runs 11 years deep, the most recent figure standing at $41.8 million for Q1 2026.

• On a quarterly basis, Inventory Average rose 14.94% year-over-year to $41.8 million in Q1 2026; TTM through Mar 2026 was $41.8 million, a 14.94% increase from a year earlier, with the FY2025 full-year figure at $38.2 million, up 12.64% from the prior year.
• Inventory Average improved to $41.8 million in Q1 2026 per COLL's latest filing, from $39.5 million in the prior quarter.
• Across five years, Inventory Average topped out at $79.0 million in Q2 2022 and bottomed at $29.5 million in Q2 2023.
• The 5-year median for Inventory Average is $37.7 million (2025), against an average of $41.9 million.
• Across the five-year window, Inventory Average soared 349.99% in 2022 and slumped 62.69% in 2023, its largest moves.
• Year by year, Inventory Average stood at $55.6 million in 2022, then slumped by 40.21% to $33.2 million in 2023, then increased by 10.74% to $36.8 million in 2024, then gained by 7.3% to $39.5 million in 2025, then advanced by 5.94% to $41.8 million in 2026.
• Per Business Quant, the three latest COLL Inventory Average figures stand at $41.8 million (Q1 2026), $39.5 million (Q4 2025), and $38.1 million (Q3 2025).